Chongo G, Soldera J
World J Transplant. 2024; 14(1):88891.
PMID: 38576762
PMC: 10989468.
DOI: 10.5500/wjt.v14.i1.88891.
de Ferrante H, van Rosmalen M, Smeulders B, Vogelaar S, Spieksma F
BMC Med Res Methodol. 2024; 24(1):51.
PMID: 38419019
PMC: 10900649.
DOI: 10.1186/s12874-024-02176-8.
Silberhumer G, Gyori G, Brugger J, Baumann L, Zehetmayer S, Soliman T
J Clin Med. 2023; 12(11).
PMID: 37297957
PMC: 10254044.
DOI: 10.3390/jcm12113763.
Goudsmit B, Braat A, Tushuizen M, Coenraad M, Vogelaar S, Alwayn I
JHEP Rep. 2021; 3(6):100369.
PMID: 34765960
PMC: 8570961.
DOI: 10.1016/j.jhepr.2021.100369.
Zhao T, Cong Q, Liu F, Yao L, Zhu Y
Front Pharmacol. 2021; 12:755625.
PMID: 34616304
PMC: 8488205.
DOI: 10.3389/fphar.2021.755625.
Joint modeling of liver transplant candidates outperforms the model for end-stage liver disease: The effect of disease development over time on patient outcome.
Goudsmit B, Braat A, Tushuizen M, Vogelaar S, Pirenne J, Alwayn I
Am J Transplant. 2021; 21(11):3583-3592.
PMID: 34174149
PMC: 8597089.
DOI: 10.1111/ajt.16730.
Delta MELD as a predictor of early outcome in adult-to-adult living donor liver transplantation.
Acar S, Akyildiz M, Gurakar A, Tokat Y, Dayangac M
Turk J Gastroenterol. 2020; 31(11):782-789.
PMID: 33361041
PMC: 7759225.
DOI: 10.5152/tjg.2020.18761.
Lymphocyte-To-Monocyte Ratio as the Best Simple Predictor of Bacterial Infection in Patients with Liver Cirrhosis.
Piotrowski D, Saczewska-Piotrowska A, Jaroszewicz J, Boron-Kaczmarska A
Int J Environ Res Public Health. 2020; 17(5).
PMID: 32155772
PMC: 7084714.
DOI: 10.3390/ijerph17051727.
Use of rapid Model for End-Stage Liver Disease (MELD) increases for liver transplant registrant prioritization after MELD-Na and Share 35, an evaluation using data from the United Network for Organ Sharing.
Brock G, Washburn K, Marvin M
PLoS One. 2019; 14(10):e0223053.
PMID: 31581270
PMC: 6776460.
DOI: 10.1371/journal.pone.0223053.
A Comprehensive Review of Outcome Predictors in Low MELD Patients.
Mazumder N, Atiemo K, Kappus M, Cullaro G, Harinstein M, Ladner D
Transplantation. 2019; 104(2):242-250.
PMID: 31517785
PMC: 6994330.
DOI: 10.1097/TP.0000000000002956.
Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation.
Cholankeril G, Li A, Dennis B, Gadiparthi C, Kim D, Toll A
Sci Rep. 2019; 9(1):8312.
PMID: 31165776
PMC: 6549161.
DOI: 10.1038/s41598-019-44814-y.
Predictive power of Model for End-Stage Liver Disease and Child-Turcotte-Pugh score for mortality in cirrhotic patients.
Piotrowski D, Saczewska-Piotrowska A, Jaroszewicz J, Boron-Kaczmarska A
Clin Exp Hepatol. 2019; 4(4):240-246.
PMID: 30603671
PMC: 6311743.
DOI: 10.5114/ceh.2018.80125.
Macrocytic anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective cross-sectional study.
Yang J, Yan B, Yang L, Li H, Fan Y, Zhu F
BMC Gastroenterol. 2018; 18(1):161.
PMID: 30384828
PMC: 6211489.
DOI: 10.1186/s12876-018-0893-9.
Transjugular intrahepatic portosystemic shunt does not independently increase risk of death in high model for end stage liver disease patients.
Spengler E, Hunsicker L, Zarei S, Zimmerman M, Voigt M
Hepatol Commun. 2018; 1(5):460-468.
PMID: 29404473
PMC: 5721420.
DOI: 10.1002/hep4.1053.
Delta model for end-stage liver disease and delta clinical prognostic indicator as predictors of mortality in patients with viral acute liver failure.
Pannu A, Bhalla A, Rao C, Singh C
Int J Crit Illn Inj Sci. 2018; 7(4):252-255.
PMID: 29291180
PMC: 5737069.
DOI: 10.4103/IJCIIS.IJCIIS_122_16.
Ascites Neutrophil Gelatinase-Associated Lipocalin Identifies Spontaneous Bacterial Peritonitis and Predicts Mortality in Hospitalized Patients with Cirrhosis.
Cullaro G, Kim G, Pereira M, Brown Jr R, Verna E
Dig Dis Sci. 2017; 62(12):3487-3494.
PMID: 29098551
DOI: 10.1007/s10620-017-4804-7.
Advances in liver transplantation allocation systems.
Schilsky M, Moini M
World J Gastroenterol. 2016; 22(10):2922-30.
PMID: 26973389
PMC: 4779916.
DOI: 10.3748/wjg.v22.i10.2922.
Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.
Cheng X, Zhao J, Chen Y, Meng F, Xu B, Yu H
Eur J Gastroenterol Hepatol. 2015; 28(4):444-8.
PMID: 26649802
PMC: 4777221.
DOI: 10.1097/MEG.0000000000000538.
MELD Score Kinetics in Decompensated HIV+/HCV+ Patients: A Useful Prognostic Tool (ANRS HC EP 25 PRETHEVIC Cohort Study).
Gelu-Simeon M, Bayan T, Ostos M, Boufassa F, Teicher E, Steyaert J
Medicine (Baltimore). 2015; 94(30):e1239.
PMID: 26222860
PMC: 4554127.
DOI: 10.1097/MD.0000000000001239.
MELD-good for many, not as good for others … at least for now.
Schiano T
Hepatol Int. 2015; 7(2):306-8.
PMID: 26201766
DOI: 10.1007/s12072-012-9393-0.